{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:12:59Z","timestamp":1779919979988,"version":"3.53.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>We previously showed that the anticancer drug imatinib mesylate (IMT, trade name: Gleevec) and a chemically distinct compound, DV2-103 (a kinase-inactive derivative of the potent Abl and Src kinase inhibitor, PD173955) lower A\u03b2 levels at low micromolar concentrations primarily through a lysosome-dependent mechanism that renders APP less susceptible to proteolysis by BACE1 without directly inhibiting BACE1 enzymatic activity, or broadly inhibiting the processing of other BACE1 substrates. Additionally, IMT indirectly inhibits \u03b3-secretase and stimulates autophagy, and thus may decrease A\u03b2 levels through multiple pathways. In two recent studies we demonstrated similar effects on APP metabolism caused by derivatives of IMT and DV2-103. In the present study, we synthesized and tested radically altered IMT isomers (IMTi\u2019s) that possess medium structural similarity to IMT. Independent of structural similarity, these isomers manifest widely differing potencies in altering APP metabolism. These will enable us to choose the most potent isomers for further derivatization.<\/jats:p>","DOI":"10.3389\/fchem.2024.1381205","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:39:20Z","timestamp":1728347960000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Stretching the structural envelope of imatinib to reduce \u03b2-amyloid production by modulating both \u03b2- and \u03b3-secretase cleavages of APP"],"prefix":"10.3389","volume":"12","author":[{"given":"William J.","family":"Netzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mondana","family":"Ghias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherina","family":"Gindinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Mui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Seon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash C.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11857","DOI":"10.1021\/acs.chemrev.9b00383","article-title":"Reductive amination in the synthesis of pharmaceuticals","volume":"119","author":"Afanasyev","year":"2019","journal-title":"Chem. Rev."},{"key":"B2","first-page":"100","article-title":"Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative","volume":"56","author":"Buchdunger","year":"1996","journal-title":"Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1124\/mol.114.097451","article-title":"Lysosomal sequestration determines intracellular imatinib levels","volume":"88","author":"Burger","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1038\/cddis.2012.111","article-title":"Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence","volume":"3","author":"Drullion","year":"2012","journal-title":"Cell. Death and Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.bbamem.2013.06.005","article-title":"\u03b3-Secretase inhibitors and modulators","volume":"1828","author":"Golde","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","article-title":"\u03b3-Secretase in Alzheimer\u2019s disease","volume":"54","author":"Hur","year":"2022","journal-title":"Exp. and Mol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1021\/ja104491h","article-title":"A coiled-coil enabled split-luciferase three-hybrid system: applied toward profiling inhibitors of protein kinases","volume":"132","author":"Jester","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1124\/dmd.112.050054","article-title":"Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)","volume":"41","author":"Kazmi","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"B9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/jad-215699","article-title":"Alzheimer\u2019s disease: Key insights from two decades of clinical trial failures","volume":"87","author":"Kim","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ejmech.2018.02.035","article-title":"Secretase inhibitors for the treatment of Alzheimer's disease: long road ahead","volume":"148","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3390\/app8071121","article-title":"A quantitative structure-property relationship model based on chaos-enhanced accelerated particle swarm optimization algorithm and back propagation artificial neural network","volume":"8","author":"Li","year":"2018","journal-title":"Appl. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/jad-201027","article-title":"Selective secretase targeting for Alzheimer\u2019s disease therapy","volume":"81","author":"Miranda","year":"2021","journal-title":"J. Alzheimer's Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1021\/cr00039a007","article-title":"Palladium-catalyzed cross-coupling reactions of organoboron compounds","volume":"95","author":"Miyaura","year":"1995","journal-title":"Chem. Rev."},{"key":"B14","first-page":"4236","article-title":"Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)","volume":"62","author":"Nagar","year":"2002","journal-title":"Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1073\/pnas.1620963114","article-title":"Gleevec shifts APP processing from a \u03b2-cleavage to a nonamyloidogenic cleavage","volume":"114","author":"Netzer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12444","DOI":"10.1073\/pnas.1534745100","article-title":"Gleevec inhibits \u03b2-amyloid production but not Notch cleavage","volume":"100","author":"Netzer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2165\/11315770-000000000-00000","article-title":"Disease-modifying approach to the treatment of Alzheimer\u2019s disease","volume":"26","author":"Panza","year":"2009","journal-title":"Drugs and Aging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3233\/jad-2010-100573","article-title":"Acute effect on the A\u03b2 isoform pattern in CSF in response to \u03b3-secretase modulator and inhibitor treatment in dogs","volume":"21","author":"Portelius","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12564","DOI":"10.1021\/acs.chemrev.6b00512","article-title":"Applications of palladium-catalyzed C\u2013N cross-coupling reactions","volume":"116","author":"Ruiz-Castillo","year":"2016","journal-title":"Chem. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e20202560","DOI":"10.1084\/jem.20202560","article-title":"Preclinical validation of a potent \u03b3-secretase modulator for Alzheimer\u2019s disease prevention","volume":"218","author":"Rynearson","year":"2021","journal-title":"J. Exp. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1021\/acsmedchemlett.9b00213","article-title":"Development of kinase inactive PD173955 analogues for reducing production of A\u03b2 peptides","volume":"10","author":"Sinha","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1021\/acs.jmedchem.8b02007","article-title":"Development of Gleevec analogues for reducing production of \u03b2-amyloid peptides through shifting \u03b2-cleavage of amyloid precursor proteins","volume":"62","author":"Sun","year":"2019","journal-title":"J. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fnmol.2020.00137","article-title":"Targeting amyloidogenic processing of APP in alzheimer's disease","volume":"13","author":"Zhao","year":"2020","journal-title":"Front. Mol. Neurosci."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2024.1381205\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:39:22Z","timestamp":1728347962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2024.1381205\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":23,"alternative-id":["10.3389\/fchem.2024.1381205"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2024.1381205","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.14.602669","asserted-by":"object"}]},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"article-number":"1381205"}}